GSK vs VTOL · P/E 13, $103.31B cap vs P/E 11, rev $1.49B
GlaxoSmithKline PLC ADR (GSK) versus Bristow Group Inc (VTOL) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Bristow Group Inc (VTOL) is a oil & gas equipment & services company listed on NYSE.
GSK does not have a complete income-statement cache yet.
Latest reported VTOL revenue for 2025-12-31 was $1.49B. Net income was $129.1M. VTOL currently screens at market cap $1.26B and trailing P/E 11.0.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. VTOL currently screens at market cap $1.26B and trailing P/E 11.0.
Not investment advice. Open the GSK and VTOL stock pages for the full models.
Not investment advice.